<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9312789</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20742</journal-id>
<journal-id journal-id-type="nlm-ta">Harv Rev Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Harv Rev Psychiatry</journal-id>
<journal-title-group>
<journal-title>Harvard review of psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1067-3229</issn>
<issn pub-type="epub">1465-7309</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26954597</article-id>
<article-id pub-id-type="pmc">4785844</article-id>
<article-id pub-id-type="doi">10.1097/HRP.0000000000000110</article-id>
<article-id pub-id-type="manuscript">NIHMS750865</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Electrophysiological Endophenotypes for Schizophrenia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Owens</surname>
<given-names>Emily</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bachman</surname>
<given-names>Peter</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Glahn</surname>
<given-names>David C</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bearden</surname>
<given-names>Carrie E</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA</aff>
<aff id="A2"><label>2</label>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA</aff>
<aff id="A3"><label>3</label>Olin Neuropsychiatric Research Center, Institute of Living, Hartford, CT</aff>
<aff id="A4"><label>4</label>Department of Psychiatry, Yale University School of Medicine, New Haven, CT</aff>
<pub-date pub-type="nihms-submitted">
<day>25</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<season>Mar-Apr</season>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>3</month>
<year>2017</year>
</pub-date>
<volume>24</volume>
<issue>2</issue>
<fpage>129</fpage>
<lpage>147</lpage>
<!--elocation-id from pubmed: 10.1097/HRP.0000000000000110-->
<abstract>
<p id="P1">Endophenotypes are quantitative, heritable traits that may help to elucidate the pathophysiologic mechanisms underlying complex disease syndromes, such as schizophrenia. They can be assessed at numerous levels of analysis; here, we review electrophysiological endophenotypes that have shown promise in helping us understand schizophrenia from a more mechanistic point of view. For each endophenotype, we describe typical experimental procedures, reliability, heritability, and reported gene and neurobiological associations. We discuss recent findings regarding the genetic architecture of specific electrophysiological endophenotypes, as well as converging evidence from EEG studies implicating disrupted balance of glutamatergic signaling and GABA-ergic inhibition in the pathophysiology of schizophrenia. We conclude that refining the measurement of electrophysiological endophenotypes, expanding genetic association studies, and integrating datasets are important next steps for understanding the mechanisms that connect identified genetic risk loci for schizophrenia to the disease phenotype.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>